“amgen” Archives

in
Entry Author Date Location
Led by Gilead Veteran Riva, Glenmark’s Ichnos Steps Out on Its Own 10/15/19 New York
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades 10/11/19 Indiana
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More 10/01/19 National
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests 09/25/19 New York
TigerGraph Raises $32M to Extend Graph Database Use to Businesses 09/25/19 San Francisco
BACEless: Eisai, Biogen Pull Plug on Alzheimer’s Drug in Final Stage 09/13/19 Boston
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More 09/13/19 National
As New CEO of Cerevel, Coles Moves From One Neuro Startup to Another 09/09/19 Boston
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More 09/09/19 National
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing 09/02/19 New York
Patent Challenge to Alexion Proceeds, But No Amgen Biosimilar Yet 08/30/19 Boston
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight 08/28/19 New York
Celgene to Sell Blockbuster Drug to Amgen for $13B to Close BMS Deal 08/26/19 New York
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.) 08/26/19 National
GSK’s Cancer Comeback Continues With Data for Multiple Myeloma Drug 08/23/19 National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Oncorus Adds $79.5M to Steer Cancer-Fighting Virus to Human Testing 08/21/19 Boston
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Boston Tech Watch: Cisco, Acacia, Great Hill Partners & GNS Healthcare 07/12/19 Boston
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More 07/12/19 National
Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs 07/11/19 National
After Amgen’s Spark, Revolution Med Nabs $100M to Push RAS Cancer Drugs 07/09/19 San Francisco
Mirati Stock Sale Targets $200M as Lead Cancer Drug Starts Phase 3 06/26/19 San Diego
Four More Through the IPO Door as Life Science Firms Raise $465M 06/20/19 National
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer 06/19/19 San Diego
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More 06/05/19 National
Page 1 of 22 next page »